![.25 tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Fragment [1-25]-Tirzepatide - Daicel Pharma](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1644654352839320)
.25 tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Fragment [1-25]-Tirzepatide - Daicel Pharma
EUR22.73
EUR61.73
Pay in 4 interest-free payments of $5.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
![.25 tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Fragment [1-25]-Tirzepatide - Daicel Pharma](https://www.daicelpharmastandards.com/wp-content/uploads/2025/04/dcti-d-571.png)
![.25 tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Fragment [1-25]-Tirzepatide - Daicel Pharma](https://plexusdx.com/cdn/shop/articles/g8_1396dc22-800d-4bc0-a33a-9de1ea7790bd.jpg?v=1781119217&width=4608)
![.25 tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Fragment [1-25]-Tirzepatide - Daicel Pharma](https://plexusdx.com/cdn/shop/articles/p10_da483808-c04e-48d0-8505-3ac3444d521e.jpg?v=1780719363&width=4608)
![.25 tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Fragment [1-25]-Tirzepatide - Daicel Pharma](https://www.daicelpharmastandards.com/wp-content/uploads/2025/04/dcti-d-542.png)
